VRNA

Q: What is the price of Verona Pharma (VRNA) today?

The price of Verona Pharma (VRNA) today is $ 0.00, with return of 0% compared to the last year. The price of Verona Pharma (VRNA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Verona Pharma (VRNA) and international markets.

Q: When does Verona Pharma (VRNA) pay dividends?

Verona Pharma (VRNA) did not distribute dividends in the last year.

Q: Is Verona Pharma (VRNA) worth it?

Currently, Verona Pharma (VRNA) is priced at $ 0.00, with a P/E of -113.24%, representing a deviation of -6,182% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Verona Pharma (VRNA) stock?

Investing in stocks of Verona Pharma (VRNA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Verona Pharma (VRNA) yield today?

The yield of Verona Pharma (VRNA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Verona Pharma (VRNA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Verona Pharma PLC

Price

$ -

return (12m)

0.00%

p/e

-113.24

p/bv

33.04

DIVIDEND YIELD

0.00%

VRNA price

VRNA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment VRNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals VRNA

review the fundamentals of Verona Pharma shares

P/E

-113.24

Sector: -2.04 Industry: 0.41

P/S (PSR)

41.48

Sector: 1.88 Industry: 2.43

P/BV

33.04

Sector: 2.11 Industry: 2.30

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-14.17%

Sector: -25.47% Industry: -24.33%

ROE

-29.18%

Sector: -29.41% Industry: -29.69%

ROIC

69.01%

Sector: -411.21% Industry: -75.87%

NET MARGIN

-36.62%

Sector: -28.27% Industry: -30.45%

GROSS MARGIN

95.15%

Sector: 44.66% Industry: 50.55%

OPERATING MARGIN

-24.29%

Sector: -23.29% Industry: -26.81%

EV/EBITDA

-263.67

Sector: -0.79 Industry: 0.98

EV/EBIT

-257.33

Sector: -2.18 Industry: -0.36

PRICE-TO-ASSETS

16.05

Sector: 1.13 Industry: 1.22

BVPS

3.24

Sector: 3.60 Industry: 4.74

EPS

-0.94

Sector: -0.89 Industry: -0.81

EQUITY-TO-ASSETS RATIO

0.49

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.51

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

40.81%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

7.88%

Sector: - Industry: -

Fundamentals VRNA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.09	32.96	86.53%	0.71%	$ 786.02 B	31.66%
ISRG	56.27	8.96	15.92%	0.00%	$ 160.69 B	28.38%
TMO	26.55	3.32	12.52%	0.36%	$ 177.98 B	15.05%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	20.29	6.10	30.04%	4.71%	$ 283.76 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	50.34	1.18	2.35%	3.80%	$ 89.00 B	0.44%
GSK	14.19	5.07	35.71%	3.10%	$ 108.22 B	17.48%
BSX	35.40	0.00	0.00%	0.00%	$ 102.58 B	14.44%
TMDX	17.70	7.12	40.22%	0.00%	$ 3.37 B	31.43%
HCA	15.86	-38.82	-244.82%	0.61%	$ 107.58 B	8.97%
IDXX	42.16	27.82	65.99%	0.00%	$ 44.67 B	24.62%
RMD	21.66	5.09	23.51%	1.06%	$ 32.19 B	27.53%
DHR	35.51	2.44	6.88%	0.71%	$ 128.33 B	14.71%
INMD	9.00	1.24	13.73%	0.00%	$ 844.20 M	25.32%
PHG	24.55	1.98	8.06%	3.31%	$ 25.47 B	5.07%
FMS	11.18	0.75	6.75%	3.57%	$ 12.62 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.41 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

VRNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Verona Pharma

Verona Pharma PLC

Average Investor10 user rating

4.0 (3 people)

United States

21 years

Founded: 2005

2017

Time since IPO - 9 years

27

Employees

The Company Verona Pharma PLC (United States), is listed on Nasdaq with a market value of $ 9.19 Billions, having an equity of $ 278.27 Millions.

With a total of 27 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 221.68 Millions, which generated a profit in the amount of $ -81.19 Millions.

As for its main indicators, the Company has a P/E ratio of -113.24, a P/BV ratio of 33.04 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker VRNA.

Market cap

$ 9.19 Billions

Net worth

$ 278.27 Millions

US$ 278,270,000.00

Assets

$ 572.87 Millions

US$ 572,870,000.00

Total Shares Outstanding

86.00 Millions

86,000,000

Average Daily Trading Volume

$ 1.14 Million

US$ 1,137,552.00

Sector

Health

Industry

Pharmaceutical Products

VRNA

VRNA revenue and profits

Financial Results VRNA

DRAG THE FRAME TO SEE MORE DATA

VRNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 14,09% (12M)

P/E

50.34

3.80%

ROE

2.35%

P/BV

1.18

CI - Cigna

$ 270.02 --18,53% (12M)

P/E

10.14

2.32%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.12 --45,37% (12M)

P/E

-2.36

0.00%

ROE

-33.28%

P/BV

0.79

HUM - Humana

$ 177.83 --31,73% (12M)

P/E

17.08

2.09%

ROE

6.70%

P/BV

1.14

HCA - HCA Healthcare

$ 471.84 36,07% (12M)

P/E

15.86

0.61%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 27,66% (12M)

P/E

38.09

0.71%

ROE

86.53%

P/BV

32.96

NVS - Novartis

$ 154.03 44,93% (12M)

P/E

20.29

4.71%

ROE

30.04%

P/BV

6.10